How are you taking part in this consultation?

You will not be able to change how you comment later.

You must be signed in to answer questions

  • Question on Consultation

    Do you agree with the proposed changes to recommendation 1.13.8?Please could you let us know if you agree or disagree (yes/no) and provide your reasons if you disagree.
  • Question on Consultation

    Do you agree with the proposed deletion of recommendation 1.13.13?Please could you let us know if you agree or disagree (yes/no) and provide your reasons if you disagree.
  • Question on Consultation

    Do you agree with the proposed changes to recommendation 1.15.10?Please could you let us know if you agree or disagree (yes/no) and provide your reasons if you disagree.
  • Question on Consultation

    Do you have any comments on equality issues related to these recommendations?Please provide sources of information on equality issues if available.
  • Question on Consultation

    Do you know of any other ongoing research in this area that may impact on the recommendations? (Yes/No)If yes, could you please provide sources of information.
The content on this page is not current guidance and is only for the purposes of the consultation process.

Methods

  • Considered the comments received by the enquirer.

  • Considered the evidence and committee rationale used to develop recommendations in the NICE guidelines on type 1 diabetes and CKD.

  • Developed a summary report (see Appendix 1) to seek views from the existing NICE diabetes committee.

  • Consultation with stakeholders (this document).